Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Yttrium-90 Radiation Lobectomy: Dose Optimization and Prediction of FLR Hypertrophy to Enable Resection of HCC

NCT04390724 is registered in ClinicalTrials.gov with Northwestern University as lead sponsor.

NCT NCT04390724
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04390724 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Yttrium-90 Radiation Lobectomy: Dose Optimization and Prediction of FLR Hypertrophy to Enable Resection of HCC
Lead sponsor
Northwestern University
Phase
Observational
Overall status
Active, not recruiting
Start date
July 17, 2020
Completion date
November 27, 2026
Enrollment
104 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

adult primary liver cancer, hcc, metastatic cancer, resection, transplant